Retina Gallery ~ Full Sized Retina Images

Más vistos - Puncate Inner Choroidopathy (PIC) and CNVM - 27 year old female 27 year old female with 4 months vision loss in the right eye. She had no subretinal fluid on presentation. Her vision improved from 20/200 to 20/50 with Lucentis. She has multifocal small scars consistent with a prior episode of PIC
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 449 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 437 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 428 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 426 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 424 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 422 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 413 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 412 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 409 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 405 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 405 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 402 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 400 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 398 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 397 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 395 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 394 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 393 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 393 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 391 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 391 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 390 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 389 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 389 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 387 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 385 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 383 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 379 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 379 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 378 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 376 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 375 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 375 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 373 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 371 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 362 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 354 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevista 337 veces27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)
38 archivos en 1 página(s)

27 year old female with 4 months vision loss in the right eye. She had no subretinal fluid on presentation. Her vision improved from 20/200 to 20/50 with Lucentis. She has multifocal small scars consistent with a prior episode of PIC